Dr. Jie An, DDS, CEO
Dr. Jie An has over ten years of experience in dentistry. She worked as a dentist and
specialized in prosthodontics. Additionally, she worked for three years in two dental colleges
as a lecturer. In November 2015, she received her doctoral degree in medical sciences from the
Radboud University. Afterwards, she continued her career in industry as a business developer for
NovioTech B.V. On July 1, 2016, she was announced CEO of NovioSpin B.V.
Françoise de Goeijen, CFO
Françoise is a business eagle and investor specialised in supporting and building startups in the
Agricultural Feed and Food industry. She has an excellent career track record in large multinational
companies, from Rhône Poulenc (today Rhodia), to ADM, DSM and Cargill. She held various independent
positions in the agricultural industry, with the task to grow the business for the company. She has
a worldwide knowledge of the agricultural business, including trends, key players and market
dynamics. Her experience varies from (fundamental) research, innovations, product development, and
market development to entrepreneurship. This combination of experience has led to start her own
business: Eagan NV. Eagan provides and secures early stage business investment for technology
startups, invests and participates in new business development within newly founded companies.
End of 2015 Françoise started NovioMosae, as sister company of NovioTech in Nijmegen. NovioMosae is
an incubator setting up companies in the southern part of the Netherlands. It is focused on the
development of IP and applications in the agricultural and the medical industry. This is realised in
close cooperation with local companies and knowledge centres.
Dr. Fang Yang, Scientific Advisor
Dr. Fang Yang is a biomaterial scientist and interested in the development and evaluation of
novel biomaterials-based approaches for tissue regeneration and the controlled delivery of
drugs or growth factors. Her current research focuses on the development of nanofibrous matrix
as an extracellular matrix with the incorporation of therapeutic agents for bone and periodontal
tissue regeneration. She is also interested in local drug delivery to prevent implant-associated
infections. Her expertise lies in biopolymers and biocomposites, electrospinning technique and
biomaterials characterization (both physicochemical and biological evaluation). She has
published more than 50 journal articles and served as a peer reviewer for about ten journals in
the related field.
Dr. Christopher Wilson, Supervisory Board Chair
Dr. Chris Wilson is CEO of NovioSense BV a medical device company based in Nijmegen. He holds a PhD
in materials chemistry has previously held an academic position at the University of Pennsylvania in
the US as well as various positions at Smith and Nephew Wound Management in the UK. Chris is a
serial entrepreneur in the medical device industry both as CEO and investor.